Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disorder, affecting approximately 1 in 3500 individuals. The most commonly seen tumors in NF1 patients are the (sub)cutaneous neurofibromas. However, individuals with NF1 typically present in childhood with well-defined pigmentary defects, including cafe-au-lait macules (CALMs), intertriginous freckling and iris Lisch nodules. NF1 is considered a neurocristopathy, primarily affecting tissues derived from the neural crest. Since the pigment producing melanocyte originates in the neural crest, the presence of (hyper)pigmentary lesions in the NF1 phenotype because of changes in melanocyte cell growth and differentiation is to be expected. We want to discuss the pigmentary cutaneous manifestations of NF1 represented by CALMs and intertriginous freckles and the pigmentary non-cutaneous manifestations represented by iris Lisch nodules. Several hypotheses have been suggested in explaining the poorly understood etiopathogenesis of CALMs. Whether other pigmentary manifestations might share similar etiopathogenic mechanisms remains obscure. Additional attention will be drawn to a readily seen phenomenon in NF1: hyperpigmentation overlying (plexiform) neurofibromas, which could suggest common etiopathogenetic-environmental cues or mechanisms underlying CALMs and neurofibromas. Finally, we want to address the relationship between malignant melanoma and NF1.
De Schepper
Sofie
S
Department of Dermatology, Ghent University, De Pintelaan 185, B-9000 Ghent, Belgium.
Boucneau
Joachim
J
Lambert
Jo
J
Messiaen
Ludwine
L
Naeyaert
Jean-Marie
JM
D019080:Cafe-au-Lait Spots / Q000209:etiology / Q000503:physiopathology; D002454:Cell Differentiation / Q000235:genetics* / Q000502:physiology; D049109:Cell Proliferation; D006801:Humans; D008544:Melanocytes / Q000473:pathology / Q000502:physiology*; D008545:Melanoma / Q000209:etiology / Q000503:physiopathology; D008548:Melanosis / Q000209:etiology / Q000503:physiopathology; D009432:Neural Crest / Q000503:physiopathology; D009456:Neurofibromatosis 1 / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D025542:Neurofibromin 1 / Q000235:genetics* / Q000378:metabolism
D025542:Neurofibromin 1